(Q30981454)

English

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003 (English)

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

antibiotic resistance

0 references

multicenter clinical trial

0 references

antimicrobial resistance

1 reference

based on heuristic

inferred from title

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

object named as

Candida

1 reference

based on heuristic

inferred from title

object named as

Lee-Jene Teng

13

0 references

object named as

Po-Ren Hsueh

1

0 references

author name string

Yeu-Jun Lau

2

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Yin-Ching Chuang

3

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jen-Hsien Wan

4

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Wen-Kuei Huang

5

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jainn-Ming Shyr

6

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jing-Jou Yan

7

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Kwok-Woon Yu

8

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Jiunn-Jong Wu

9

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Wen-Chien Ko

10

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Yi-Chueh Yang

11

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Yung-Ching Liu

12

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Cheng-Yi Liu

14

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Kwen-Tay Luh

15

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

49

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

512-517

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

The role of antifungal susceptibility testing in the therapy of candidiasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Azole cross-resistance in Aspergillus fumigatus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Antifungal drug resistance in Aspergillus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Fungal empyema thoracis: an emerging clinical entity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Global Antifungal Surveillance Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Current and emerging azole antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

Itraconazole resistance in Aspergillus fumigatus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

21 June 2018

In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547329

25 November 2018

Guidelines for treatment of candidiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15673726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.49.2.512-517.2005

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30981454&oldid=2164528441"